NASDAQ: BTTX - Better Therapeutics, Inc.

छह महीने के लिए लाभप्रदता: -99.12%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Better Therapeutics, Inc.


कंपनी के बारे में

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions.

अधिक जानकारी
In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

EBITDA -0.0057
EV/EBITDA -0.7443
IPO date 2021-10-28
ISIN US08773T1043
Industry Biotechnology
P/BV 3.35
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 1.8E-5
Сайт https://www.bettertx.com
Цена ао 0.0137
Число акций ао 0.02356 млрд
प्रति दिन मूल्य परिवर्तन: 0% (0.0001)
प्रति सप्ताह मूल्य परिवर्तन: 0% (0.0001)
प्रति माह मूल्य परिवर्तन: 0% (0.0001)
3 महीने में कीमत में बदलाव: 0% (0.0001)
छह महीने में कीमत में बदलाव: -99.12% (0.0113)
प्रति वर्ष मूल्य परिवर्तन: -99.95% (0.195)
3 वर्षों में मूल्य परिवर्तन: -100% (4.65)
5 वर्षों में मूल्य परिवर्तन: 0% (0.0001)
10 वर्षों में मूल्य परिवर्तन: 0% (0.0001)
वर्ष की शुरुआत से मूल्य परिवर्तन: 0% (0.0001)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV -35.64 0
P/E 0 0
EV/EBITDA -0.8149 0
कुल: 2.5

क्षमता

नाम अर्थ श्रेणी
ROA, % -107.6 0
ROE, % -221.99 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.389 10
कुल: 9.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 0 0
लाभप्रदता Ebitda, % 523.39 10
लाभप्रदता EPS, % 217.59 10
कुल: 8

संस्थानों आयतन शेयर करना, %
MMCAP International, Inc. SPC 356270 0.71
Citadel Advisors Llc 216165 0.43
Vanguard Group Inc 198154 0.4
Geode Capital Management, LLC 168821 0.34
Millennium Management LLC 128749 0.26
Blackrock Inc. 88635 0.18
Capital Investment Advisory Services, LLC 71000 0.14
State Street Corporation 58600 0.12
Susquehanna International Group, LLP 38057 0.08
Corient Private Wealth LLC 29180 0.06



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. David P. Perry M.B.A. Co-Founder & Executive Chairman 260k 1968 (57 साल)
Mr. Frank L. Karbe CEO, Interim CFO, President & Director 533.37k 1968 (57 साल)
Dr. Mark A. Berman M.D. Chief Medical Officer 573.75k 1976 (49 साल)
Ms. Kristin Wynholds Chief Product Officer 519.07k 1973 (52 वर्ष)
Mr. Andres Camacho Senior VP of Technology & Head of Engineering N/A
Ms. Angela Willis Senior Vice President of Market Access N/A
Leslie Miller Controller N/A
Ms. Jessica Meng Chief Commercial Officer N/A

पता: United States, San Francisco. CA, 548 Market Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.bettertx.com